Diagnosis and Management of Pulmonary Arterial Hypertension
Author Information
Author(s): Jeanne Houtchens, Douglas Martin, James R. Klinger
Primary Institution: Rhode Island Hospital, Alpert Medical School of Brown University
Conclusion
Pulmonary arterial hypertension (PAH) is a rare but serious disease that requires early diagnosis and treatment to improve patient outcomes.
Supporting Evidence
- PAH is characterized by increased pulmonary vascular resistance and can lead to right heart failure if untreated.
- Early diagnosis is crucial for better management and outcomes in PAH patients.
- Various classes of medications have been developed to treat PAH, improving patient prognosis.
Takeaway
Pulmonary arterial hypertension is a condition that makes it hard for blood to flow through the lungs, causing tiredness and shortness of breath. Doctors use special tests to find it and different medicines to help people feel better.
Methodology
The article reviews the pathophysiology, classification, epidemiology, clinical presentation, diagnostic testing, and treatment options for pulmonary arterial hypertension.
Limitations
The article does not provide specific data on the effectiveness of treatments or long-term outcomes for patients with PAH.
Participant Demographics
Approximately 2/3 of PAH patients are female, and the disease can occur at any age, with peak incidence in the fourth and fifth decades of life.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website